Search results for "prostatectomy"

showing 10 items of 105 documents

PSA and PSA Kinetics Thresholds for the Presence of 68Ga-PSMA-11 PET/CT-Detectable Lesions in Patients with Biochemical Recurrent Prostate Cancer

2020

68Ga-PSMA-11 positron-emission tomography/computed tomography (PET/CT) is commonly used for restaging recurrent prostate cancer (PC) in European clinical practice. The goal of this study is to determine the optimum time for performing these PET/CT scans in a large cohort of patients by identifying the prostate-specific-antigen (PSA) and PSA kinetics thresholds for detecting and localizing recurrent PC. This retrospective analysis includes 581 patients with biochemical recurrence (BC) by definition. The performance of 68Ga-PSMA-11 PET/CT in relation to the PSA value at the scan time as well as PSA kinetics was assessed by the receiver-operating-characteristic-curve (ROC) generated by plottin…

Biochemical recurrenceCancer Researchmedicine.medical_treatment68Gallium-PSMA PET/CTurologic and male genital diseaseslcsh:RC254-282030218 nuclear medicine & medical imaging03 medical and health sciencesProstate cancer0302 clinical medicine<sup>68</sup>gallium-psma pet/ctprostate-specific-antigenPSA kinetics thresholdsbiochemical recurrenceMedicineoptimal cutoff levelPET-CTPsa kineticsbusiness.industryProstatectomylcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensprostate cancermedicine.diseaseRadiation therapyProstate-specific antigenOncology030220 oncology & carcinogenesisRecurrent prostate cancerbusinessNuclear medicineCancers
researchProduct

Impact of preoperative risk on metastatic progression and cancer-specific mortality in patients with adverse pathology at radical prostatectomy.

2017

Objective To evaluate the impact of preoperative risk category on metastatic disease and prostate cancer-specific mortality (CSM) in patients with prostate cancer (PCa) with adverse pathology at radical prostatectomy (RP). Patients and Methods The records of 6 943 patients who underwent RP at a European tertiary centre were analysed. Biochemical recurrence (BCR), metastatic disease and CSM were assessed for patients with adverse pathology at RP, and stratified according to preoperative low- vs intermediate-/high-risk PCa groups. Kaplan–Meier, cumulative incidence, Cox regression and competing risk regression analyses were performed. Results In patients with extracapsular extension, the meta…

Biochemical recurrenceMalemedicine.medical_specialtyPathologyUrologymedicine.medical_treatment030232 urology & nephrologyUrologyKaplan-Meier EstimateLower riskCohort Studies03 medical and health sciencesProstate cancer0302 clinical medicineRisk FactorsMedicineHumansCumulative incidencePathologicalAgedProstatectomybusiness.industryProportional hazards modelProstatectomyHazard ratioProstatic NeoplasmsMiddle AgedProstate-Specific Antigenmedicine.disease030220 oncology & carcinogenesisMultivariate AnalysisbusinessBJU international
researchProduct

Radiation therapy after radical prostatectomy: what has changed over time?

2021

The role and timing of radiotherapy (RT) in prostate cancer (PCa) patients treated with radical prostatectomy (RP) remains controversial. While recent trials support the oncological safety of early salvage RT (SRT) compared to adjuvant RT (ART) in selected patients, previous randomized studies demonstrated that ART might improve recurrence-free survival in patients at high risk for local recurrence based on adverse pathology. Although ART might improve survival, this approach is characterized by a risk of overtreatment in up to 40% of cases. SRT is defined as the administration of RT to the prostatic bed and to the surrounding tissues in the patient with PSA recurrence after surgery but no …

Biochemical recurrenceOncologymedicine.medical_specialtyRD1-811medicine.medical_treatmentMedizinReviewDisease030218 nuclear medicine & medical imaging03 medical and health sciencesProstate cancer0302 clinical medicineInternal medicinebiochemical recurrencegenomic classifiersmedicineddc:610hormonal therapyProstatectomybusiness.industrysalvage radiotherapyprostate cancermedicine.diseaseRadiation therapyadjuvant radiotherapy; biochemical recurrence; genomic classifiers; hormonal therapy; prostate cancer; salvage radiotherapy030220 oncology & carcinogenesisHormonal therapySurgeryHormone therapybusinessadjuvant radiotherapyAdjuvant
researchProduct

Intraoperative peripheral frozen sections do not significantly affect prognosis after nerve-sparing radical prostatectomy for prostate cancer

2010

Study Type – Therapy (outcomes research) Level of Evidence 2b What’s known on the subject? and What does the study add? We hypothesized that taking intraoperative frozen section (FS) biopsies of the peripheral margins of resection during radical prostatectomy would allow an intraoperative systematic scan of resection margins. In the case of positive FS, extended resection could be performed with the aim of completely excising residual tumour, improving biochemical recurrence-free survival of patients with positive surgical margins at the inked specimen. To our knowledge, the prognostic value of achieving a negative resection status by systematically taking intraoperative FS of the periphera…

Biochemical recurrencemedicine.medical_specialtybusiness.industryProstatectomyUrologymedicine.medical_treatmentSurgeryNeck of urinary bladderProstate-specific antigenMedicineProstate neoplasmProstate surgeryPositive Surgical MarginStage (cooking)businessBJU International
researchProduct

Evaluation of TKTL1 as a biomarker in serum of prostate cancer patients.

2016

Introduction Monocyte associated transketolase-like 1 (TKTL1) as a cancer biomarker has become popular with alternative practitioners, but plays no role in conventional medicine. This investigation evaluates the potential of serum TKTL1 as a biomarker for prostate cancer. Material and methods Patients (n = 66) undergoing curative radical prostatectomy (RPE) for biopsy-pro-ven PCa were included in the study. Controls (n = 10) were healthy, age-matched, male volunteers. 10 ml of peripheral blood was drawn from patients several days before surgery and from controls. Serum TKTL1 was measured using the ELISA method. Results The median age at tumor diagnosis was 66 years and median serum PSA was …

Conventional medicineOncologymedicine.medical_specialtydiagnosismedicine.medical_treatmentTKTL102 engineering and technologyGastroenterology03 medical and health sciencesProstate cancer0302 clinical medicineInternal medicineTumor stagemedicinecomplementary medicineElisa methodOriginal PaperProstatectomybusiness.industryMonocyteGleason SumGeneral Medicine021001 nanoscience & nanotechnologymedicine.diseaseprostate cancerPeripheral bloodmedicine.anatomical_structure030220 oncology & carcinogenesisbiomarker0210 nano-technologybusinessCentral European journal of urology
researchProduct

Adherence to Guidelines among Italian Urologists on Imaging Preoperative Staging of Low-Risk Prostate Cancer: Results from the MIRROR (Multicenter It…

2011

Objective. A number of evidence-based guidelines for diagnosis and management of prostate cancer have been published. The aim of this study is to evaluate the adherence of Italian urologists to the guidelines concerning the preoperative imaging staging of prostate cancer.Methods. In October 2007 a multicentric observational perspective study called Multicentric Italian Report on Radical prostatectomy Outcome and Research (MIRROR) was started in 135 Italian urology centers. Recruitment was closed in December 2008 and 2,408 cases were collected. In this paper we have taken into consideration all examinations carried out for preoperative imaging staging, evaluating compliance with the recommen…

Gynecologymedicine.medical_specialtyArticle Subjectbusiness.industryProstatectomyUrologyGeneral surgerymedicine.medical_treatmentObstetrics and Gynecologylcsh:Diseases of the genitourinary system. Urologylcsh:RC870-923Gleason grademedicine.diseaseManagement of prostate cancerProstate cancerPreoperative stagingClinical StudyMedicineObservational studyProstatic Neoplasms Bone and Bones scan indexbusinessCost of carePreoperative imagingAdvances in urology
researchProduct

Risk of adverse pathology at prostatectomy in the era of MRI and targeted biopsies; rethinking active surveillance for intermediate risk prostate can…

2021

Abstract Purpose Men with intermediate risk (IR) prostate cancer (CaP) are often excluded from active surveillance (AS) due to higher rates of adverse pathology (AP). We determined our rate of AP in men who underwent multiparametric MRI (MpMRI) with combined biopsy (CB) consisting of targeted biopsy (TB) and systematic biopsy (SB) prior to radical prostatectomy (RP). Methods A retrospective review was conducted of men with Gleason Grade Group (GG) 2 disease who underwent RP after SB alone or after preoperative MRI with CB. AP was defined as either pathologic stage T3a (AP ≥ T3a) or pathologic stage T3b (AP ≥ T3b) and/or GG upgrading. Rates of AP were determined for both groups and those who…

Image-Guided BiopsyMalePathologymedicine.medical_specialtyUrologymedicine.medical_treatment030232 urology & nephrologyDiseaseGleason gradeLogistic regression03 medical and health sciencesProstate cancer0302 clinical medicineBiopsymedicineHumansRetrospective StudiesProstatectomymedicine.diagnostic_testbusiness.industryProstatectomyProstateProstatic NeoplasmsCancerMiddle Agedmedicine.diseaseMagnetic Resonance ImagingOncology030220 oncology & carcinogenesisbusinessIntermediate riskUrologic Oncology: Seminars and Original Investigations
researchProduct

Added Value of Multiparametric Magnetic Resonance Imaging to Clinical Nomograms for Predicting Adverse Pathology in Prostate Cancer

2018

PURPOSE: We examined the additional value of preoperative prostate multiparametric magnetic resonance imaging and transrectal ultrasound/multiparametric magnetic resonance imaging fusion guided targeted biopsy when performed in combination with clinical nomograms to predict adverse pathology at radical prostatectomy. MATERIALS AND METHODS: We identified all patients who underwent 3 Tesla multiparametric magnetic resonance imaging prior to fusion biopsy and radical prostatectomy. The Partin and the MSKCC (Memorial Sloan Kettering Cancer Center) preradical prostatectomy nomograms were applied to estimate the probability of organ confined disease, extraprostatic extension, seminal vesicle inva…

Image-Guided BiopsyMalePathologymedicine.medical_specialtyUrologymedicine.medical_treatment030232 urology & nephrologyMagnetic Resonance Imaging InterventionalRisk AssessmentArticle03 medical and health sciencesProstate cancer0302 clinical medicinePredictive Value of TestsProstatePreoperative CareImage Processing Computer-AssistedmedicineHumansProspective StudiesUltrasonography InterventionalMultiparametric Magnetic Resonance ImagingAgedRetrospective Studiesbusiness.industryProstatectomyProstateProstatic NeoplasmsMiddle AgedNomogrammedicine.diseaseMagnetic Resonance ImagingPI-RADSProstate-specific antigenNomogramsmedicine.anatomical_structure030220 oncology & carcinogenesisFeasibility StudiesBiopsy Large-Core NeedleNeoplasm GradingbusinessImage-Guided Biopsyhuman activities
researchProduct

Role of apparent diffusion coefficient values in prostate diseases characterization on diffusion-weighted magnetic resonance imaging.

2019

BACKGROUND: To evaluate if normal and pathological prostate tissue can be distinguished by using apparent diffusion coefficient (ADC) values on magnetic resonance imaging (MRI) and to understand if it is possible to differentiate among pathological prostate tissues using ADC values.METHODS:Our population consisted in 81 patients (mean age 65.4 years) in which 84 suspicious areas were identified. Regions of interest were placed over suspicious areas, detected on MRI, and over areas with normal appearance, and ADC values were recorded. Statistical differences between ADC values of suspicious and normal areas were evaluated. Histopathological diagnosis, obtained from targeted biopsy using MRI-…

Image-Guided BiopsyMaleProstatic DiseasesProstate DiseasesUrologymedicine.medical_treatmentPopulation030232 urology & nephrologyurologic and male genital diseases030218 nuclear medicine & medical imagingDiffusion03 medical and health sciencesProstate cancer0302 clinical medicineProstateImage Processing Computer-AssistedmedicineHumansEffective diffusion coefficienteducationAgedRetrospective StudiesAged 80 and overProstate MRI Diffusion Weighted ImagingAtypical small acinar proliferationeducation.field_of_studymedicine.diagnostic_testbusiness.industryProstatectomyProstateProstatic NeoplasmsMagnetic resonance imagingMiddle Agedmedicine.diseasebody regionsDiffusion Magnetic Resonance Imagingmedicine.anatomical_structureNephrologyNeoplasm GradingbusinessNuclear medicineAlgorithms
researchProduct

Use of psycho‐oncological services by prostate cancer patients: A multilevel analysis

2020

Abstract Background Cancer patients often suffer from psychological distress. Psycho‐oncological services (POS) have been established in some health care systems in order to address such issues. This study aims to identify patient and center characteristics that elucidate the use of POS by patients in prostate cancer centers (PCCs). Methods Center‐reported certification and patient survey data from 3094 patients in 44 certified PCCs in Germany were gathered in the observational study (Prostate Cancer Outcomes). A multilevel analysis was conducted. Results Model 1 showed that utilization of POS in PCCs is associated with patients’ age (OR = 0.98; 95%‐CI = 0.96‐0.99; P < .001), number of como…

Male0301 basic medicineCancer Researchmedicine.medical_treatmentprostate neoplasmsAndrogen deprivation therapyProstate cancer0302 clinical medicineProspective StudiesOriginal ResearchAged 80 and overProstatectomyHealth services researchpsychosocial oncologyMiddle AgedPrognosisprostate cancerlcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensCombined Modality Therapyhealth services researchOncology030220 oncology & carcinogenesismultilevel analysisAdultmedicine.medical_specialtyPsycho-Oncologylcsh:RC254-28203 medical and health sciencesInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingWatchful WaitingAgedProstatectomybusiness.industryPsychosocial Support SystemsProstatic NeoplasmsClinical Cancer ResearchCancerAndrogen Antagonistsmedicine.diseasePsychotherapy030104 developmental biologypsycho‐oncologyProstate neoplasmObservational studybusinessWatchful waitingFollow-Up StudiesCancer Medicine
researchProduct